The latest price target for Alzamend Neuro (NASDAQ:ALZN) was reported by Ascendiant Capital on December 16, 2024. The analyst firm set a price target for $32.00 expecting ALZN to rise to within 12 months (a possible 2757.14% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Alzamend Neuro (NASDAQ:ALZN) was provided by Ascendiant Capital, and Alzamend Neuro maintained their buy rating.

There is no last upgrade for Alzamend Neuro

There is no last downgrade for Alzamend Neuro.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alzamend Neuro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alzamend Neuro was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.

While ratings are subjective and will change, the latest Alzamend Neuro (ALZN) rating was a maintained with a price target of $35.00 to $32.00. The current price Alzamend Neuro (ALZN) is trading at is $1.12, which is out of the analyst’s predicted range.